Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.74
Delayed Data
As of 4:00pm ET
 -0.04 / -1.06%
Today’s Change
1.29
Today|||52-Week Range
5.03
+135.22%
Year-to-Date

Today’s Trading

Previous close3.78
Today’s open3.75
Day’s range3.70 - 3.86
Volume3,109,639
Average volume (3 months)1,446,068
Market cap$549.0M
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+18.11%
Earnings growth (this year)-19.61%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
VKTXViking Therapeutics ...-0.42-5.78%
AKBAAkebia Therapeutics ...-0.01-0.22%
AKROAkero Therapeutics I...+0.87+4.83%
LCILannett Company Inc+0.39+2.91%
Data as of 4:10pm ET, 09/20/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$70.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph Truitt
Chief Operating Officer &
Executive Vice President
Paul Firuta
Corporate headquarters
Blue Bell, Pennsylvania

Forecasts